Category Pharmaceuticals and Biotech
Three Senior Pharma R&D Leaders Join BenchSci's Science Advisory Board
Steve Hitchcock, Philip Larsen, and Philip Tagari named science advisors, providing BenchSci with global industry expertise to realize its vision of using machine learning to bring novel medicine to patients 50% faster by 2025
Read Press Release
Universal DX Presents Data at EACR Virtual Congress; Top-Scoring Poster Shows Accurate Detection of Colorectal Advanced Adenomas
New results from the OMICS study, the company's prospective, international, multi-center study, show Universal DX's blood test can detect colorectal advanced adenomas at 55% sensitivity and 90% specificity, which exceeds currently available non-invasive tests for colorectal cancer screening
80% of sporadic colorectal cancers arise from pre-malignant advanced adenomas, making early detection critical to saving lives
AtbFinder Test System Shows Promise to Select Effective Antibiotic Regimens to Fight Deadly Lung Infections
TGV-Dx Reports Its Diagnostic Test Demonstrates Breakthrough Results, Selecting Antibiotics Effective Even Against Multidrug-Resistant Bacteria That Cause Chronic and Untreatable, by Usual Care, Infections in Patients with Cystic Fibrosis
Read Press Release
Direct Biologics Receives FDA Approval to Proceed with Second ExoFlo IND for Post-Acute COVID-19 Syndrome and Chronic Post-COVID-19 Syndrome
Extracellular Vesicle Isolate Product ExoFlo Shows Strong Potential to Treat COVID-19, Post-Acute COVID-19 Syndrome, and Chronic Post-COVID-19 Syndrome; 60-patient trial to be conducted nationally at ambulatory infusion sites
Read Press Release
3Brain AG CorePlate™ technology combines microchips and AI in a revolutionary new approach to drug discovery
3Brain AG has announced a new technology based on a unique combination of microchips and AI that promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials - and to maximize their chances of success.
Read Press Release
Cancer Prevention and Early Detection Are One Step Closer as Universal DX Announces Breakthrough Study Results From Its Multi-Omics + Computational Biology + ML Blood Test
New results from the OMICS study, which will be presented at ASCO, show Universal DX's blood test can detect colorectal cancer with extraordinary accuracy (92% sensitivity/97% specificity), which exceeds currently available non-invasive tests for colorectal cancer screening. Early detection cancer screening via a liquid biopsy is not only critical to save lives, but is a vast market opportunity, ranging between $30B and $75B in the U.S. alone
Read Press Release
Recardio Completes Phase 2 Regenerative Post-Myocardial Infarction Trial of Dutogliptin
Recardio Inc., a clinical-stage life science company focusing on regenerative therapies for cardiovascular diseases, announced the completion of its Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction.
Read Press Release